Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, please find enclosed herewith certificate received from KFIN Technologies Limited, Registrar & Share ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mahamaya Lifesciences has submitted a certificate from its Registrar & Share Transfer Agent, KFIN Technologies, to BSE under SEBI Regulation 74(5) for the quarter ended 31 December 2025. The regulation requires the RTA to confirm details of shares held in physical form and any re-materialization requests received during the quarter. KFIN Technologies has confirmed that the regulation is not applicable to the company because the entire shareholding is held in demat form. No requests for re-materialization were received from any shareholder during the quarter.
This is a routine procedural compliance filing with no impact on the company's financials, operations, or stock price. It simply confirms that all shares are already in dematerialized form.